Results 31 to 40 of about 492,944 (298)

Difficult to treat absence seizures in children: A single-center retrospective study

Frontiers in Neurology, 2022
ObjectivesThe aim of this study was to analyse the characteristics of typical absence seizures (AS), myoclonic AS and AS with eyelid myoclonia in children and to find associations between these characteristics and difficult to treat absence seizures ...
Samo Gregorčič, Jaka Hrovat, Neli Bizjak, Neli Bizjak, Zvonka Rener Primec, Zvonka Rener Primec, Tadeja Hostnik, Blaž Stres, Blaž Stres, Blaž Stres, Mirjana Perković Benedik, Mirjana Perković Benedik, Damjan Osredkar, Damjan Osredkar   +13 more
doaj   +1 more source

Naïve vs. switchers differences in treatment effectiveness in spondyloarthritis [PDF]

Romanian Journal of Rheumatology, 2021
Introduction. Treat-to-target concept in spondyloarthritis (SpA) is a highly disputed subject. Up to the present, there is no evaluation score that integrates the clinical and laboratory/imaging results for defining remission in SpA.
Irina Andrada Craciun, Relu Liviu Craciun, Sanziana Elena Daia-Iliescu, Ruxandra Ionescu   +3 more
doaj   +1 more source

Can remission be in juvenile idiopathic arthritis without the use of biological agents?

Современная ревматология, 2019
Objective: to evaluate the efficiency and safety of therapy with subcutaneous (SC) methotrexate (MTX) in patients with juvenile idiopathic arthritis (JIA) without systemic manifestations.Patients and methods.
S. I. Valieva, A. A. Glazyrina, N. N. Kuleshov, M. S. Dzis, S. Kh. Kurbanova, A. S. Sologub, E. A. Korobiyants, V. T. Yusupova   +7 more
doaj   +1 more source

Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy

Clinical Case Reports, 2021
DS‐ALL has a higher rate of relapse and treatment‐related mortality. The newer immunotherapies are potentially better options. Relapsed ALL with positive MRD has a poor prognosis.
Zhongbo Hu, Kristen A. VanHeyst, Jignesh Dalal, Lisa Hackney   +3 more
doaj   +1 more source

The significance of sleep quality in euthymic bipolar patients from Nigeria

South African Journal of Psychiatry, 2022
Background: Bipolar disorder is highly under-researched in Africa. Existing studies show that racial/ethnic disparities exist for sleep quality. Poor sleep quality in bipolar disorder causes significant morbidity and mortality even during periods of ...
Oluyomi Esan, Ayodele Fela-Thomas
doaj   +1 more source

Evaluation of the efficiency and safety of tocilizumab therapy in patients with systemic-onset juvenile idiopathic arthritis: results of a retrospective follow-up

Современная ревматология, 2018
Objective: to study the efficiency and safety of tocilizumab (TCZ) therapy in patients with systemic-onset juvenile idiopathic arthritis (sJIA). Patients and methods.
M. M. Kostik, E. A. Isupova, I. A. Chikova, M. F. Dubko, V. V. Masalova, L. S. Snegireva, O. V. Kalashnikova, V. G. Chasnyk   +7 more
doaj   +1 more source

Optimization of systemic juvenile arthritis treatment regimens with correction of tocilizumab intravenous administration according to data of observational retrospective study

Научно-практическая ревматология, 2019
Objective: to assess the possibility of using varying interval between intravenous infusions of tocilizumab (TCZ) as a tool for choosing the optimal treatment regimen in systemic juvenile arthritis (SJA).Subjects and methods.
M. I. Kaleda, I. P. Nikishina, O. M. Kostareva   +2 more
doaj   +1 more source

Influence of Cytokines and Autologous Lymphokine-Activated Killer Cells on Leukemic Bone Marrow Cells and Colonies in AML [PDF]

, 2001
We have already shown that cytokine cocktails (IL-1 beta, IL-3, IL-6, SCF, GM-CSF) and/or lymphokine-activated killer (LAK) cells can reduce the amounts of clonal, CD34-positive mononuclear bone marrow cells (BM-MNC) in acute myeloid leukemia (AML).
Gerhartz, Helmut Heinrich, Schmetzer, Helga Maria, Braun, Susanne Walburg   +2 more
core   +1 more source

The efficacy and safety of apremilast in patients with psoriatic arthritis concurrent with comorbidity in clinical practice

Научно-практическая ревматология, 2019
Objective: to evaluate the clinical efficacy and safety of the targeted synthetic disease-modifying antirheumatic drug (DMARD) apremilast (AP; Otesla®) in patients with active psoriatic arthritis (PsA) at 14 and 26 weeks after starting the treatment and ...
E. Yu. Loginova, Yu. L. Korsakova, A. D. Koltakova, E. E. Gubar, P. L. Karpova, S. I. Glukhova, T. V. Korotaeva   +6 more
doaj   +1 more source

Ultrasound remission in patients with rheumatoid arthritis in clinical remission

Rheumatology, 2021
ObjectivesThe aim of the study was to assess ultrasound (US) remission in patients with rheumatoid arthritis (RA) in clinical remission using different definitions.Material and methodsThis was a cross-sectional study including patients with RA in clinical remission defined by disease activity score (DAS28) – erythrocyte sedimentation rate (ESR) ≤ 2.6 ...
Rym Fakhfakh, Nejla Elamri, Khadija Baccouche, Sadok Laataoui, Hela Zeglaoui, Elyes Bouajina   +5 more
openaire   +3 more sources